116 related articles for article (PubMed ID: 34394844)
1. Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein.
Hu X; Chen CZ; Xu M; Hu Z; Guo H; Itkin Z; Shinn P; Ivin P; Leek M; Liang TJ; Shen M; Zheng W; Hall MD
ACS Med Chem Lett; 2021 Aug; 12(8):1267-1274. PubMed ID: 34394844
[TBL] [Abstract][Full Text] [Related]
2. Ca
Khelashvili G; Plante A; Doktorova M; Weinstein H
bioRxiv; 2021 Jan; ():. PubMed ID: 33299996
[TBL] [Abstract][Full Text] [Related]
3. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
4. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ
bioRxiv; 2021 Oct; ():. PubMed ID: 34642691
[TBL] [Abstract][Full Text] [Related]
5. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
[TBL] [Abstract][Full Text] [Related]
6. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
7. Discovery of TMPRSS2 inhibitors from virtual screening.
Hu X; Shrimp JH; Guo H; Xu M; Chen CZ; Zhu W; Zakharov A; Jain S; Shinn P; Simeonov A; Hall MD; Shen M
bioRxiv; 2021 Mar; ():. PubMed ID: 33398276
[TBL] [Abstract][Full Text] [Related]
8. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
Romeo A; Iacovelli F; Falconi M
Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
10. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.
Liang T; Qiu J; Niu X; Ma Q; Zhou C; Chen P; Zhang Q; Chen M; Yang Z; Liu S; Li L
Front Pharmacol; 2020; 11():603830. PubMed ID: 33519467
[TBL] [Abstract][Full Text] [Related]
11. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
[TBL] [Abstract][Full Text] [Related]
12. Deep Drug Discovery of Mac Domain of SARS-CoV-2 (WT) Spike Inhibitors: Using Experimental ACE2 Inhibition TR-FRET Assay, Screening, Molecular Dynamic Simulations and Free Energy Calculations.
Iqbal S; Lin SX
Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627846
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.
Cannalire R; Stefanelli I; Cerchia C; Beccari AR; Pelliccia S; Summa V
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784899
[TBL] [Abstract][Full Text] [Related]
14. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
Verkhivker G
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
[TBL] [Abstract][Full Text] [Related]
15. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
Di Paola L; Hadi-Alijanvand H; Song X; Hu G; Giuliani A
J Proteome Res; 2020 Nov; 19(11):4576-4586. PubMed ID: 32551648
[TBL] [Abstract][Full Text] [Related]
16. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
17. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.
Beddingfield BJ; Iwanaga N; Chapagain PP; Zheng W; Roy CJ; Hu TY; Kolls JK; Bix GJ
JACC Basic Transl Sci; 2021 Jan; 6(1):1-8. PubMed ID: 33102950
[TBL] [Abstract][Full Text] [Related]
18. Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.
Allam L; Ghrifi F; Mohammed H; El Hafidi N; El Jaoudi R; El Harti J; Lmimouni B; Belyamani L; Ibrahimi A
Bioinform Biol Insights; 2020; 14():1177932220965505. PubMed ID: 33149560
[TBL] [Abstract][Full Text] [Related]
19. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.
Sheikhi A; Hojjat-Farsangi M
Hum Vaccin Immunother; 2021 Jan; 17(1):92-97. PubMed ID: 32663051
[TBL] [Abstract][Full Text] [Related]
20. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2.
Olaleye OA; Kaur M; Onyenaka CC
bioRxiv; 2020 Sep; ():. PubMed ID: 32995775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
